Drug Development

Listings
  • Anti-TNFRSF8 (Brentuximab)-VC-PAB-MMAE ADC

    Anti-TNFRSF8 (Brentuximab)-VC-PAB-MMAE ADC

    Drug Development Shirley (New York) January 18, 2018 1.00 Dollar US$

    https://www.creative-biolabs.com/adc/target-tnfrsf8-99.htm This ADC product is comprised of an Anti-TNFRSF8 antibody (Brentuximab) conjugated via a VC-PAB linker to MMAE. The MMAE is targeted to certain cancers by immunerecognition and delivered into...

  • Anti-TNFRSF8 (cAC10)-DIBO-doxorubicin ADC

    Anti-TNFRSF8 (cAC10)-DIBO-doxorubicin ADC

    Drug Development Shirley (New York) January 18, 2018 1.00 Dollar US$

    https://www.creative-biolabs.com/adc/target-tnfrsf8-99.htm This ADC product is comprised of an anti-TNFRSF8 monoclonal antibody (cAC10) conjugated via a DIBO linker to a doxorubicin. The doxorubicin is targeted to certain cancers by immunerecognition...

  • Anti-CD30 receptorc (cAC10)-Mc-VC-PABC-MMAF ADC

    Anti-CD30 receptorc (cAC10)-Mc-VC-PABC-MMAF ADC

    Drug Development Shirley (New York) January 18, 2018 1.00 Dollar US$

    https://www.creative-biolabs.com/adc/target-tnfrsf8-99.htm This ADC product is comprised of an anti-TNFRSF8 monoclonal antibody (cAC10) conjugated via a Mc-VC-PABC linker to a MMAF. The MMAF is targeted to certain cancers by immunerecognition and del...

  • Anti-TNFRSF8  (cAC10)-Mc-MMAF ADC

    Anti-TNFRSF8 (cAC10)-Mc-MMAF ADC

    Drug Development New York (New York) January 18, 2018 1.00 Dollar US$

    https://www.creative-biolabs.com/adc/target-tnfrsf8-99.htm This ADC product is comprised of an anti-TNFRSF8 monoclonal antibody (cAC10) conjugated via a MC linker to a MMAF. The MMAF is targeted to certain cancers by immunerecognition and delivered i...

  • Anti-TNFRSF8 (clone Ki4) scFv-MAP ADC

    Anti-TNFRSF8 (clone Ki4) scFv-MAP ADC

    Drug Development Shirley (New York) January 18, 2018 1.00 Dollar US$

    https://www.creative-biolabs.com/adc/target-tnfrsf8-99.htm This ADC product is comprised of an anti-TNFRSF8 monoclonal antibody (clone Ki4) conjugated via a linker to a MAP.

  • Anti-TNFRSF8 (cCA10)-β-glucuronide-doxorubicin propyloxazoline (DPO) ADC

    Anti-TNFRSF8 (cCA10)-β-glucuronide-doxorubicin propyloxazoline (DPO) ADC

    Drug Development Shirley (New York) January 18, 2018 1.00 Dollar US$

    https://www.creative-biolabs.com/adc/target-tnfrsf8-99.htm This ADC product is comprised of an anti-TNFRSF8 monoclonal antibody (cCA10) conjugated via a β-glucuronide linker to a doxorubicin propyloxazoline (DPO). The doxorubicin propyloxazoline (DPO...

  • Anti-TNFRSF8 (cCA10)-β-glucuronide-MMAF ADC

    Anti-TNFRSF8 (cCA10)-β-glucuronide-MMAF ADC

    Drug Development Shirley (New York) January 18, 2018 1.00 Dollar US$

    https://www.creative-biolabs.com/adc/target-tnfrsf8-99.htm This ADC product is comprised of an anti-TNFRSF8 monoclonal antibody (cCA10) conjugated via a β-glucuronide linker to a MMAF. The MMAF is targeted to certain cancers by immunerecognition and ...

  • Anti-TNFRSF8 (CA10)-β-glucuronide-MMAE ADC

    Anti-TNFRSF8 (CA10)-β-glucuronide-MMAE ADC

    Drug Development Shirley (New York) January 18, 2018 1.00 Dollar US$

    https://www.creative-biolabs.com/adc/target-tnfrsf8-99.htm This ADC product is comprised of an anti-TNFRSF8 monoclonal antibody (CA10) conjugated via a β-glucuronide linker to a MMAE. The MMAE is targeted to certain cancers by immunerecognition and d...

  • Anti-ITGAE (clone M290)-MCC-DM1 ADC

    Anti-ITGAE (clone M290)-MCC-DM1 ADC

    Drug Development Shirley (New York) December 18, 2017 1.00 Dollar US$

    https://www.creative-biolabs.com/adc/target-itgae-59.htm This ADC product is comprised of an anti-ITGAE monoclonal antibody (clone M290) conjugated via a MCC linker to DM1. The DM1 is targeted to certain cancers by immunerecognition and delivered int...

  • Anti-ITGAE (clone M290)-Mc-MMAF ADC

    Anti-ITGAE (clone M290)-Mc-MMAF ADC

    Drug Development Shirley (New York) December 18, 2017 1.00 Dollar US$

    https://www.creative-biolabs.com/adc/target-itgae-59.htm This ADC product is comprised of an anti-ITGAE monoclonal antibody (clone M290) conjugated via a Mc linker to MMAF. The MMAF is targeted to certain cancers by immunerecognition and delivered in...

  • Anti-ITGAE (clone M290)-Mc-VC-PABC-MMAE ADC

    Anti-ITGAE (clone M290)-Mc-VC-PABC-MMAE ADC

    Drug Development Shirley (New York) December 18, 2017 1.00 Dollar US$

    https://www.creative-biolabs.com/adc/target-itgae-59.htm This ADC product is comprised of an anti-ITGAE monoclonal antibody (clone M290) conjugated via a Mc-VC-PABC linker to MMAE. The MMAE is targeted to certain cancers by immunerecognition and deli...

  • Anti-IL2RA-PBD ADC

    Anti-IL2RA-PBD ADC

    Drug Development Shirley (New York) December 18, 2017 1.00 Dollar US$

    https://www.creative-biolabs.com/adc/target-il2ra-58.htm This ADC product is comprised of an anti-IL2RA monoclonal antibody conjugated via a linker to PDB. The PDB is targeted to certain cancers by immunerecognition and delivered into cancer cells vi...